SEC Comment Letter 0000000000-24-010203 to Zura Bio Ltd (ZURA)
Zura Bio Ltd
Date: Sept. 10, 2024 · CIK: 0001855644 · Accession: 0000000000-24-010203
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281905
Letter
September 10, 2024 Verender Badial Chief Financial Officer Zura Bio Limited 1489 W. Warm Springs Rd. #110 Henderson, NV 89014 Re:Zura Bio Limited Registration Statement on Form S-3 Filed September 3, 2024 File No. 333-281905 Dear Verender Badial: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Sarah Sellers, Esq.
Show Raw Text
September 10, 2024
Verender Badial
Chief Financial Officer
Zura Bio Limited
1489 W. Warm Springs Rd. #110
Henderson, NV 89014
Re:Zura Bio Limited
Registration Statement on Form S-3
Filed September 3, 2024
File No. 333-281905
Dear Verender Badial:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Sarah Sellers, Esq.